|
Mutation Information
|
Mutation Site
|
T215I |
|
Mutation Type
|
Amino acid level |
|
Gene/Protein/Region Type
|
RT |
|
Viral Reference
|
subtype A (92UG-UGO37;
94SE-SE7523;
94KE-Q23);
subtype B (90US-WEAU160;
86US-JFRL;
83FR-HXB2);
subtype C (86ET-ETH2220;
96BW-0502;
95IN-21068);
subtype D (94UG-114;
83CD-NDK;
99TCMN011);
subtype F1 (93BR-20;
93BE-VI850;
93FI-FIN9363);
subtype F2 (95CM-MP255;
CM-MP257;
CM53657);
subtype G (93SE-SE61615;
93FIHH8793;
96DE-DRCBL);
subtype H (90CF-CF056;
BE.VI991;
BE.VI997);
subtype J (93SE-SE92809 93SE-SE91733);
subtype K (97CD-EQTB11 96CM-MP535);
CRF02_AG (IBNG;
DJ263;
98SE-MP1211);
CRF06_cpx (BFP90 95ML-84);
CRF09 (96GH2911;
95SN1795;
95SN7808). |
|
Relevant Drug
|
NRTIs |
|
Country
|
Côte d'Ivoire |
Literature Information
|
PubMed PMID
|
33170745
|
|
Disease
|
HIV infection/AIDS
|
|
Published Year
|
2021 |
|
Journal
|
Genome |
|
Title
|
Determination of reverse transcriptase inhibitor resistance mutations in HIV-1 infected children in Côte d'Ivoire. |
|
Author
|
Camara-Cisse M,Djohan YF,Toni TD,Dechi JR,N'Din JP,Lohoues EE,Monde AA,Gogbe LO,Brou E,Fieni F,Mansour FA,Aby R,Kouakou K,Chenal H |
|
Evidence
|
Frequently encountered resistance mutations were for NRTIs: M184V (88%), TAMs (67%), T215F/I/V/Y (33%) and L74I/V (24%);for NNRTIs: K103N/S (74%), P225H (26%) and G190A/E/Q (24%).
|
|
|
HIV Mutation Detail Information